VALRATE CR 200MG TABLET
₹32*
MRP ₹35.5
10% off
₹30.5*
MRP ₹35.5
15% CB
₹5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
VALRATE CR 200MG TABLET belongs to a group of medications known as 'anti-arrhythmic' primarily used to treat arrhythmia (irregular heartbeat) in patients with paroxysmal (sudden attack) or persistent atrial fibrillation (irregular heartbeat due to poor blood flow). Besides this, VALRATE CR 200MG TABLET is also used to treat 'cardioversion' which is a medical procedure that changes the abnormal heartbeat to a normal rhythm. Arrhythmia is a problem associated with the rate of rhythm at which the heartbeats.
VALRATE CR 200MG TABLET contains 'Dronedarone' a Class III anti-arrhythmic drug that restores normal heart rhythm and reduces heart rate in atrial fibrillation. VALRATE CR 200MG TABLET blocks abnormal electrical signals in the heart. Also, it prevents ventricular fibrillation (a rapid contraction of heart muscle) and ventricular tachycardia (lower chambers of the heart ventricles that beat quickly than normal).
Take VALRATE CR 200MG TABLET as prescribed by your doctor. Your dose and duration of VALRATE CR 200MG TABLET will be advised by your doctor, depending upon your medical condition. In some cases, you may experience slow heartbeat, diarrhoea, nausea and vomiting. Most of these side effects of VALRATE CR 200MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Please inform your doctor if you are using any prescription, non-prescription drugs, including vitamins and herbal products. Let your doctor know if you have any allergic reactions to VALRATE CR 200MG TABLET or any other medicines, before starting VALRATE CR 200MG TABLET. Inform your doctor if you have heart, kidney or liver problems and electrolyte imbalance. It is advised to consult a doctor if you are a pregnant or breastfeeding mother. VALRATE CR 200MG TABLET is not recommended for use during pregnancy. Do not stop taking VALRATE CR 200MG TABLET without consulting your doctor since it may worsen your condition and increase the risk of future heart problems.
VALRATE CR 200MG TABLET contains Dronedarone, a class III anti-arrhythmic drug. It treats arrhythmia (irregular heartbeat) in patients with paroxysmal (sudden attack) or persistent atrial fibrillation (irregular heartbeat due to poor blood flow). It blocks abnormal electrical signals in the heart and works by restoring normal heart rhythm. It also prevents ventricular fibrillation (a rapid contraction of heart muscle) and ventricular tachycardia (lower chambers of the heart (ventricles) beat quickly than normal). VALRATE CR 200MG TABLET is used in cardioversion, a medical procedure that changes the abnormal heartbeat to a normal rhythm.
Brief your medical history to the doctor if you have any heart problems liver, kidney diseases and electrolyte imbalance (low potassium and magnesium) before starting VALRATE CR 200MG TABLET. VALRATE CR 200MG TABLET may affect QT prolongation (heart muscle takes longer than usual to recharge between beats) that can cause serious fast/irregular heartbeat. Hence it is advised to inform your doctor if you have heart-related problems like heart failure, slow heartbeat and a family history of heart diseases. VALRATE CR 200MG TABLET is contraindicated during pregnancy since it has harmful effects on the foetus. Consult your doctor before using VALRATE CR 200MG TABLET if you are a breastfeeding mother. Do not drive or operate machinery if you experience any side effects that affect your ability to concentrate and drive. Avoid consumption of alcohol with VALRATE CR 200MG TABLET as it may decrease the efficacy of VALRATE CR 200MG TABLET. VALRATE CR 200MG TABLET is not recommended in patients younger than 18 years of age.
Drug-Drug Interaction: VALRATE CR 200MG TABLET may interact with antibiotics (ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin, telithromycin), HIV drugs (lopinavir, ritonavir, rifampin), fits medicines (carbamazepine, phenobarbital, phenytoin), antidepressants (nefazodone, flibanserin), multiple sclerosis treating drugs (fingolimod), blood thinners (dabigatran) and heart-related drugs (digoxin).
Drug-Food Interaction: Avoid grapefruit and its products to prevent the occurrence of side effects of VALRATE CR 200MG TABLET.
Drug-Disease Interaction: People with heart problems, liver and kidney diseases, and electrolyte imbalance (low levels of potassium and magnesium) should consult the doctor before taking VALRATE CR 200MG TABLET. VALRATE CR 200MG TABLET is contraindicated in patients with class IV heart failure requiring hospitalization or referral to a specialized heart failure clinic.
Arrhythmia: It is a problem associated with the rate of rhythm at which the heart beats. Generally, in this condition, the heart beats too fast, too slow or with an irregular rate. It can lead to severe heart damage. A cardiac arrhythmia occurs when there are abnormal electrical signals in the heart. When the heart beats too fast, it is known as tachycardia, and if it is too slow, it is called bradycardia. Treatment of arrhythmia includes drugs, medical procedures, implantable devices and sometimes surgery.
Alcohol
Caution
It is advised to limit alcohol intake when you are being treated with VALRATE CR 200MG TABLET.
Pregnancy
Unsafe
VALRATE CR 200MG TABLET is a pregnancy category X drug, so it is not recommended and unsafe in pregnancy. It can affect and harm the developing baby. Please seek medical advice for more information.
Breast Feeding
Caution
It is not known if VALRATE CR 200MG TABLET is excreted into the breast milk. Due to possible effects on the breastfed infant, VALRATE CR 200MG TABLET is not recommended for use if you are a nursing mother. Please consult your doctor for more information before taking VALRATE CR 200MG TABLET.
Driving
Caution
VALRATE CR 200MG TABLET is possibly safe and does not affect your ability to drive. However, if you experience any symptoms that may affect your mental focus and ability to drive, do not drive or operate machinery until you feel better.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking VALRATE CR 200MG TABLET. Your doctor will weigh the benefits and any potential risks before prescribing VALRATE CR 200MG TABLET.
Kidney
Caution
Let your doctor know if you have any history of kidney diseases before taking VALRATE CR 200MG TABLET. Your doctor will weigh the benefits and any potential risks before prescribing VALRATE CR 200MG TABLET.
Children
Unsafe
Safety and effectiveness of VALRATE CR 200MG TABLET have not been established in patients below 18 years of age.
Country of origin
Manufacturer/Marketer address